Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL M KARPECKI

Eye and Vision Services Providers Optometrist

NPI
1619910569
CMS profile
73016
Location
LEXINGTON, KY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$519,797.84

373 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Mallinckrodt Hospital Products Inc. $124,266.20 101
Bausch & Lomb Americas Inc. $89,063.92 97
Tarsus Pharmaceuticals, Inc. $58,156.40 43
Oasis Medical, Inc. $54,000.00 1
Harrow Eye, LLC $42,416.60 18
BIOTISSUE HOLDINGS INC. $30,374.37 11
RxSight Inc $22,000.00 4
Atlas Ocular, Inc $18,000.00 1
Dompe US, Inc. $15,533.70 14
Nordic Pharma, Inc. $14,355.56 1
OCULUS, Inc. $13,500.00 3
SUN PHARMACEUTICAL INDUSTRIES INC. $9,467.97 12
Sight Sciences, Inc. $7,900.00 10
Topcon Healthcare, Inc. $6,219.03 6
ABBVIE INC. $5,955.38 13
Oyster Point Pharma, Inc. $2,163.26 12
Alcon Research LLC $2,000.00 1
Alcon Vision LLC $1,934.85 9
TearLab Corp $1,566.56 6
Carl Zeiss Meditec, Inc. $250.00 1
TOPCON CORPORATION $238.37 1
Apellis Pharmaceuticals, Inc. $236.50 1
Thea Pharma Inc. $65.03 1
Amgen Inc. $55.90 3
ANI Pharmaceuticals, Inc. $53.52 2
Ocular Therapeutix, Inc. $24.72 1

Page 4 of 8; records 151–200 of 373 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL M KARPECKI

NPI 1619910569 · CMS profile ID 73016

Eye and Vision Services Providers / Optometrist

LEXINGTON, KY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 8; records 151–200 of 373 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619910569?year=2024&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL M KARPECKI, NPI 1619910569, CMS profile ID 73016. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 373 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619910569?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). PAUL M KARPECKI, NPI 1619910569, CMS profile ID 73016. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 8; records 151–200 of 373 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619910569?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
PAUL M KARPECKI, NPI 1619910569, CMS profile ID 73016, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 8; records 151–200 of 373 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1619910569?year=2024&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

373 matching records · $519,797.84 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 373 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 373.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Harrow Eye, LLC $22.0007/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145606168 CMS
Amgen Inc. $20.2707/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115789525 CMS
OCULUS, Inc. $4,500.0007/24/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142988662 CMS
Tarsus Pharmaceuticals, Inc. $9,843.7507/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139106853 CMS
Dompe US, Inc. $925.0007/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151413379 CMS
Dompe US, Inc. $4,340.0007/23/2024 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151413381 CMS
BIOTISSUE HOLDINGS INC. $20.5107/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148769082 CMS
Sight Sciences, Inc. $750.0007/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151934301 CMS
Bausch & Lomb Americas Inc. $2,400.0007/16/2024 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425454 CMS
TearLab Corp $22.3607/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150244036 CMS
Bausch & Lomb Americas Inc. $89.1007/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425466 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $1,512.5007/11/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1155059589 CMS
ABBVIE INC. $600.0007/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103135867 CMS
Bausch & Lomb Americas Inc. $27.2907/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425464 CMS
Mallinckrodt Hospital Products Inc. $19.3707/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090450 CMS
Oyster Point Pharma, Inc. $18.7107/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147399726 CMS
Mallinckrodt Hospital Products Inc. $10,000.0007/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090442 CMS
Mallinckrodt Hospital Products Inc. $10,750.0007/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090446 CMS
Mallinckrodt Hospital Products Inc. $102.4606/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090426 CMS
Mallinckrodt Hospital Products Inc. $209.1106/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090430 CMS
Mallinckrodt Hospital Products Inc. $847.9506/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090434 CMS
Mallinckrodt Hospital Products Inc. $18.0406/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090438 CMS
Sight Sciences, Inc. $550.0006/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151934295 CMS
Alcon Vision LLC $4.9506/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110563199 CMS
Bausch & Lomb Americas Inc. $171.3406/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425444 CMS
Bausch & Lomb Americas Inc. $60.7306/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425452 CMS
Bausch & Lomb Americas Inc. $174.1406/25/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425460 CMS
Tarsus Pharmaceuticals, Inc. $29.0006/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139106851 CMS
Mallinckrodt Hospital Products Inc. $502.2006/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090393 CMS
Mallinckrodt Hospital Products Inc. $322.9406/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090397 CMS
Mallinckrodt Hospital Products Inc. $125.0006/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090401 CMS
Mallinckrodt Hospital Products Inc. $35.2006/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090405 CMS
Mallinckrodt Hospital Products Inc. $60.0006/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090409 CMS
Mallinckrodt Hospital Products Inc. $32.2006/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090413 CMS
Mallinckrodt Hospital Products Inc. $32.2006/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090417 CMS
Mallinckrodt Hospital Products Inc. $36.8706/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090422 CMS
Mallinckrodt Hospital Products Inc. $925.0006/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090385 CMS
Mallinckrodt Hospital Products Inc. $10.2006/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090389 CMS
Oyster Point Pharma, Inc. $23.7006/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147400322 CMS
Alcon Vision LLC $750.0006/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110518666 CMS
Bausch & Lomb Americas Inc. $1,800.0006/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425440 CMS
Harrow Eye, LLC $24.6206/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145606166 CMS
Tarsus Pharmaceuticals, Inc. $128.9306/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139106849 CMS
Bausch & Lomb Americas Inc. $1,800.0006/19/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425382 CMS
Bausch & Lomb Americas Inc. $64.5406/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140425384 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $38.0806/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152190218 CMS
Oyster Point Pharma, Inc. $500.0006/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147401198 CMS
Dompe US, Inc. $120.8306/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151413377 CMS
Mallinckrodt Hospital Products Inc. $7,700.0006/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090377 CMS
Mallinckrodt Hospital Products Inc. $7,700.0006/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145090381 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $544,436.51 367
PY2020 $473,532.89 207
PY2021 $528,809.65 261
PY2022 $444,990.43 271
PY2023 $458,819.60 266
PY2024 $519,797.84 373
PY2025 $594,015.68 397

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $7,765.18 9
PY2022 Recipient $3,043.00 1
PY2020 Principal investigator $53,420.40 3
PY2019 Principal investigator $27,313.88 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Glaukos Corporation $104.56 11/27/2024 Non-covered Recipient Entity
Fisher Scientific
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787221
Principal investigator 1 Glaukos Corporation $104.55 11/27/2024 Non-covered Recipient Entity
Fisher Scientific
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787233
Principal investigator 1 Glaukos Corporation $25.22 11/27/2024 Non-covered Recipient Entity
Lexitas Pharma Services Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151789311
Principal investigator 1 Glaukos Corporation $348.24 11/13/2024 Non-covered Recipient Entity
OCPC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787219
Principal investigator 1 Glaukos Corporation $940.05 10/30/2024 Non-covered Recipient Entity
Sherpa Clinical Packaging, LLC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787237
Principal investigator 1 Glaukos Corporation $33.10 10/23/2024 Non-covered Recipient Entity
Amazon.com, Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787231
Principal investigator 1 Glaukos Corporation $2,828.70 10/02/2024 Non-covered Recipient Entity
Sherpa Clinical Packaging, LLC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787239
Principal investigator 1 Glaukos Corporation $8.13 08/21/2024 Non-covered Recipient Entity
Amazon.com, Inc.
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787227
Principal investigator 1 Glaukos Corporation $3,372.63 06/26/2024 Non-covered Recipient Entity
Sherpa Clinical Packaging, LLC
A Randomized, Multicenter, Double-Masked, Vehicle -Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON (Lufepirsen Ophthalmic Gel) in Subjects with Persistent Corneal Epithelial Defects (NEXPEDE-1) No dispute reported 06/30/2026 1151787243

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2024 Amount invested $225.00 1
PY2024 Value of interest $36,675.00 1
PY2023 Amount invested $225.00 1
PY2023 Value of interest $36,675.00 1
PY2022 Amount invested $310.00 3
PY2022 Value of interest $58,916.40 3
PY2021 Amount invested $335.00 4
PY2021 Value of interest $27,560.00 4
PY2020 Amount invested $30,335.00 5
PY2020 Value of interest $54,835.00 5
PY2019 Amount invested $30,310.00 3
PY2019 Value of interest $30,310.00 3

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

17 records · PY2019–2024

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2024 Amaros, Inc. $225.00 $36,675.00 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 1144039027
PY2023 Amaros Medical $225.00 $36,675.00 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 1045157431
PY2022 Amaros Medical $225.00 $36,675.00 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 952369635
PY2022 RxSight Inc $0.00 $17,991.40 Fully Vested Options Physician Covered Recipient No dispute reported 06/30/2026 958919067
PY2022 Visant Medical, Inc. $85.00 $4,250.00 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 956710423
PY2021 Amaros Medical $225.00 $225.00 Stock Option Exercise Physician Covered Recipient No dispute reported 06/30/2026 831682751
PY2021 Omera Medical, Inc. $25.00 $25.00 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 835406241
PY2021 RxSight Inc $0.00 $27,225.00 Fully Vested Options Physician Covered Recipient No dispute reported 06/30/2026 849773695
PY2021 Visant Medical, Inc. $85.00 $85.00 Stock Option Exercise. Physician Covered Recipient No dispute reported 06/30/2026 831387147
PY2020 Amaros Medical $225.00 $225.00 Stock Options with 48-month Vesting Physician Covered Recipient No dispute reported 06/30/2026 719646147
PY2020 Eyevance Pharmaceuticals LLC $30,000.00 $30,000.00 Equity interest Physician Covered Recipient No dispute reported 06/30/2026 752251265
PY2020 Omera Medical, Inc. $25.00 $25.00 Stock Options with 48-month vesting Physician Covered Recipient No dispute reported 06/30/2026 722704595
PY2020 RxSight Inc $0.00 $24,500.00 Fully Vested Options Physician Covered Recipient No dispute reported 06/30/2026 752951883
PY2020 Visant Medical, Inc. $85.00 $85.00 Stock Options with 48-Month Vesting Physician Covered Recipient No dispute reported 06/30/2026 717234503
PY2019 Amaros Medical $225.00 $225.00 Common Stock of Amaros Medical, Inc. Physician Covered Recipient No dispute reported 06/30/2026 694968145
PY2019 Eyevance Pharmaceuticals LLC $30,000.00 $30,000.00 3000 units @$10.00 each Physician Covered Recipient No dispute reported 06/30/2026 703481615
PY2019 Visant Medical, Inc. $85.00 $85.00 Common Stock of Visant Medical, Inc. Physician Covered Recipient No dispute reported 06/30/2026 692463489